Denali Therapeutics (DNLI) Depreciation and Depletion (2017 - 2018)
Denali Therapeutics' (DNLI) quarterly Depreciation and Depletion came in at $2.3 million in Q3 2018, up 199.1% year-on-year from $778000.0 in Q3 2017, and up 25.44% on a QoQ basis from $1.9 million in Q2 2018.
Denali Therapeutics (DNLI) Depreciation and Depletion (2017 - 2018) Analysis & Trends
Denali Therapeutics (DNLI) has 2 years of Depreciation and Depletion data on file, last reported at $2.3 million in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 39.39 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 2.20 Mn |
| 10 | Denali Therapeutics | 4.33 Bn | 4.33 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 2.33 Mn |
| Sep 30, 2018 | 2.33 Mn |
| Jun 30, 2018 | 1.86 Mn |
| Jun 30, 2018 | 1.86 Mn |
| Mar 31, 2018 | 854,000.00 |
| Mar 31, 2018 | 854,000.00 |
| Sep 30, 2017 | 778,000.00 |
| Sep 30, 2017 | 778,000.00 |
| Jun 30, 2017 | 766,000.00 |
| Jun 30, 2017 | 766,000.00 |
| Mar 31, 2017 | 731,000.00 |
| Mar 31, 2017 | 731,000.00 |